Blog | Drive Therapeutics

RJ Quick

Jul 27, 20211 min

Drive Therapeutics awarded a Phase 1 SBIR from the NSF

Drive was recently awarded a $256,000 Phase 1 SBIR grant from the NSF to help continue development of our novel, aptamer based inhibitors...

RJ Quick

Feb 5, 20211 min

Drive Receives Funding from NC Biotech Center

Drive Therapeutics of Research Triangle Park received $100,000 to develop a novel nucleic acid therapy to block angiogenesis,...

RJ Quick

Jul 9, 20202 min

Welcome Doug Gooding to the Drive Therapeutics Team!

Doug has agreed to join the team as CEO and help us navigate fundraising, early stage company formation, and relationship formation...

RJ Quick

Apr 23, 20201 min

Go Aptamers Go!!

Exciting news out of the University of Louisville.....

Blog: Blog2